Dr. Alireza Faridar, MD

Dr. Faridar practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Faridar's NPI, 1902240740, was assigned on April 23, 2013. Dr. Faridar graduated from Tehran University of Medical Sciences School of Medicine in 2008. Dr. Faridar holds Texas license R3320.

Dr. Faridar's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Faridar's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Faridar is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Faridar to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faridar practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Faridar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Faridar is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Faridar is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, non-alzheimer's dementia (chronic), parkinson's disease and sleep apnea among the conditions Dr. Faridar treats.

CMS data shows 148 Medicare services from Dr. Faridar across 2 procedure codes in 2024, all of them office visits, for 110 Medicare patients. Medicare paid $20,175 for them. Every service was in an office.

CMS counts 110 Medicare patients who saw Dr. Faridar in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Faridar's median patient age at 77, with 56% women.

In 2024, Dr. Faridar wrote 1,559 Medicare Part D claims for 181 patients. 99% of them were for generic drugs. CMS names the drug for 1,479 of them, across 16 drugs with 11 or more claims each, at $25,508 in total drug cost. In 2023, CMS named 1,315 claims across 15 drugs.

Dr. Faridar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Faridar as offering telehealth.

Dmand AI links 25 papers to Dr. Faridar, published from 2010 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Inflammation, Kidney Transplantation and Alzheimer Disease. Dr. Faridar has published most often in Front Neurol. Dr. Faridar's most frequent co-authors are Stanley H. Appel, MD, Jason Robert Thonhoff, MD, PhD and Joseph C. Masdeu, MD, PhD.

Dmand AI links Dr. Faridar to 3 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Alzheimer Disease and Tauopathies. The Methodist Hospital Research Institute sponsors the most, 3.

CMS Open Payments shows 227 general payments to Dr. Faridar from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Eli Lilly and Company paid the most, $418.

Dmand AI lists 2 awards for Dr. Faridar, most recently BrightFocus Alzheimer Disease Research Fellowship Award in 2019.

Dr. Faridar graduated from Tehran University of Medical Sciences School of Medicine in 2008.

Dr. Faridar is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.